Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Explore clinical trials studying Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) trial results

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

NCT02953938

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +9 more
Locations: Novartis Investigative Site Nagakute, Aichi-ken, Japan

Novartis Investigative Site Fukuoka, Japan

Novartis Investigative Site Kita-gun, Kagawa-ken, Japan

Novartis Investigative Site Tsu, Mie-ken, Japan

View Trial Details

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) trial results

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Related conditions